Options for the development of coagulopathy in COVID-19

dc.contributor.author	Egamberdiyeva Gulchehra
dc.date.accessioned	2026-01-02T11:32:48Z
dc.date.issued	2023-03-30
dc.description.abstract	The mechanisms of COVID-19-associated coagulopathy (CAC) are complex and differ in many ways from the standard mechanisms of thrombosis in critically ill patients. This review presents the pathogenesis, diagnosis and comparison of different types of coagulopathy with SAS. In the course of COVID-19 infection, the number of cases of sudden death outside the hospital has increased. One possible reason is the high rate of serious thrombotic events in patients with COVID-19. However, the pathogenesis of these life-threatening events is multifactorial and requires independent discussion
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/emrp/article/view/3718
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/77529
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/emrp/article/view/3718/3145
dc.source	Eurasian Medical Research Periodical; Vol. 18 (2023): EMRP; 115-122
dc.source	2795-7624
dc.subject	COVID-19-associated coagulopathy
dc.subject	sepsis-induced coagulopathy
dc.subject	thromboelastography
dc.title	Options for the development of coagulopathy in COVID-19
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: gulchehra_2023_options_for_the_development_of_coagulopa.pdf
item.page.filesection.size: 280.01 KB
item.page.filesection.format: Adobe Portable Document Format